• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 3. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Maleimides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidones Maleimides

Introduction to 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione (CAS No. 73383-82-1)

1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione is a heterocyclic compound with significant relevance in the field of pharmaceutical chemistry and medicinal biology. Its molecular structure, featuring a pyrrole core with benzyl and methyl substituents, makes it a versatile scaffold for the development of bioactive molecules. This compound has garnered attention due to its potential applications in drug discovery and as an intermediate in synthetic chemistry.

The chemical formula of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione is C₁₂H₁₃N₃O₂, reflecting its composition of carbon, hydrogen, nitrogen, and oxygen atoms. The presence of two carbonyl groups at the 2 and 5 positions of the pyrrole ring contributes to its reactivity, enabling various functionalization strategies that are crucial for medicinal chemistry applications.

In recent years, there has been growing interest in exploring the pharmacological properties of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione and its derivatives. The pyrrole moiety is a common structural feature in many biologically active compounds, including antimicrobial, anti-inflammatory, and anticancer agents. The benzyl and methyl groups in this compound not only enhance its solubility but also modulate its interactions with biological targets.

One of the most compelling aspects of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione is its role as a precursor in the synthesis of more complex pharmacophores. Researchers have leveraged its structural framework to develop novel molecules with improved pharmacokinetic profiles and enhanced therapeutic efficacy. For instance, derivatives of this compound have been investigated for their potential in inhibiting specific enzymes involved in disease pathways.

The synthesis of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione typically involves multi-step organic reactions that highlight the compound's synthetic utility. The introduction of the benzyl group at the 1-position and the methyl group at the 3-position can be achieved through various coupling reactions and cyclization processes. These synthetic pathways are well-documented in chemical literature and provide a robust foundation for further modifications.

Recent advancements in computational chemistry have further accelerated the exploration of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione and its derivatives. Molecular modeling studies have revealed insights into how structural modifications can influence biological activity. For example, computational docking experiments have identified key interactions between this compound and target proteins, providing a rational basis for designing more potent analogs.

The pharmaceutical industry has taken notice of the potential of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione as a lead compound for drug development. Several academic and industrial groups have reported on their efforts to optimize its pharmacological properties through structure-based drug design. These efforts include modifications aimed at improving binding affinity, selectivity, and metabolic stability.

In addition to its pharmaceutical applications, 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione has shown promise in material science research. Its ability to form coordination complexes with metal ions makes it a valuable candidate for developing functional materials with applications in catalysis and sensing.

The safety profile of 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole-2,5-dione is another critical consideration in its application. Preliminary toxicology studies have indicated that this compound is well-tolerated at moderate doses under controlled conditions. However，further research is necessary to fully characterize its safety profile before clinical translation.

The future direction of research on 1-benzyl-3-methyl-2,5-dihydro-1H-pyrrole - - dione is likely to focus on expanding its therapeutic applications and understanding its mechanism of action at a molecular level. Collaborative efforts between chemists，biologists，and clinicians will be essential in translating laboratory findings into tangible benefits for patients.

• 119462-56-5(1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)